ITGAM and neoplasm: In both Renca and MB49 tumor models, CD11b+Gr1+ cells represent a heterogeneous group of immature myeloid cells, MDSCs, specifically after CpG-STAT3ASO treatment, and neutrophils with antitumor activity (24).